3/A//SEC Filing
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3/A
Accession 0001144204-18-063387
CIK 0001478069other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:35 PM ET
Size
5.4 KB
Accession
0001144204-18-063387
Insider Transaction Report
Form 3/AAmended
CONTRAFECT CorpCRFX
Holdings
- (indirect: by Fosun Industrial Co., Limited)
Warrants (right to buy)
Exercise: $1.55Exp: 2022-07-25→ Common Stock (4,250,000 underlying)
Footnotes (2)
- [F1]These warrants are only exercisable to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would not beneficially own more than 9.99% of the outstanding Common Stock of the Issuer after giving effect to such exercise, as such percentage ownership is determined in accordance with the terms of the warrant (the "Beneficial Ownership Limitation"), except that upon at least 61 days prior notice from the holder to the Issuer, the holder may waive the Beneficial Ownership Limitation. This Beneficial Ownership Limitation was not taken into account in the Form 3 filed by the Reporting Person on August 18, 2017.
- [F2]Fosun Industrial Co., Limited is a wholly owned subsidiary of the Reporting Person.
Documents
Issuer
CONTRAFECT Corp
CIK 0001478069
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0001615258
Filing Metadata
- Form type
- 3/A
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:35 PM ET
- Size
- 5.4 KB